Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

New Medical Studies on Nerve Stimulation Migraine Treatment Offer Hope to Patients Suffering from Severe Migraine Headaches
  • USA - English


News provided by

Reed Migraine Centers

Aug 06, 2013, 03:00 ET

Share this article

Share toX

Share this article

Share toX

Dr. Ken Reed and Reed Migraine Treatment Center's Partner Physicians
Dr. Ken Reed and Reed Migraine Treatment Center's Partner Physicians

Dallas, TX (PRWEB) August 06, 2013 -- The recent Congress of the International Headache Society held in Boston was the venue for two new medical reports that documented implantable nerve stimulation migraine treatment to be highly successful in over 80% of patients suffering from severe, chronic migraine headaches.

Implantable nerve stimulation was found to be highly successful in over 80% of the patients.

Post this

Dr. Ken Reed of "Reed Migraine Centers" in Dallas, TX explained that similar success rates were found in both the adult and adolescent patient groups. “In a review of 171 consecutive patients with frequent, severe migraines treated for up to three years, we were very pleased to find that 85% of the patients reported good to excellent results,” said Dr. Reed. “In fact 50% of the patients reported near complete migraine relief.”

The Reed Procedure ®, a migraine treatment technically known as “Combined Supraorbital and Occipital Nerve Stimulation” was first described in a landmark paper published in 2010 in “Cephalalgia,” the Journal of the International Headache Society. It received the society's prestigious “Cephalalgia Award” for the best original research contribution to the journal that year. “We were very grateful to the Society for this award, particularly considering the quality of the competition from the top institutions around the world,” said Dr. Reed. “It is always very gratifying to have your colleagues recognize the work that you are doing.

Dr. Robert Bulger of the "Southwest Pain Group" in Dallas, TX emphasized that the same remarkable success rate was also found in the adolescent patient group. “We saw dramatic improvement in well over 80% of our teenage patients,” said Dr. Bulger. “It is just most gratifying to have our patients come back smiling, as they report their pleasure at returning to their schools, their activities, and to their friends. These kids have their lives back.”

A co-author on the current studies, Dr. Sukdeb Datta, at the “Laser Spine and Pain Institute” and Professorial Lecturer at Mt. Sinai Medical Center in New York, explained that the migraine treatment procedure actually involves two steps – the first being a test or trial stimulator, which is very reliable in determining whether, and how well, a patient will respond to the actual full neurostimulator implant. “One of the many nice things about the implantable neurostimulation is that we have the ability to actually test the treatment to indeed make sure that it’s going to work, before we perform the full implant,” said Dr. Datta. “Our patients are of course very pleased with this, as it allows them to know with great confidence just how well the treatment will work before they have the actual full procedure.”

Lauren Smith, Director of Operations and Physician Services for Reed Migraine Centers, indicated that patient information seminars are being scheduled around the country for those who would like more information on the Reed Procedure®. “For those patients who have uncontrolled migraine headaches, I would strongly recommend that they attend one of our seminars and hear Dr. Reed personally discuss the full details of the treatment,” said Ms. Smith. “Patients can find the schedule for the upcoming seminars on our website, where they also can find additional information about the Reed Procedure ®.”

About Reed Migraine Centers:
Reed Migraine Centers partners with recognized and highly respected pain management physicians to provide individuals who suffer from chronic migraine headaches with access to the most effective migraine treatments available. Reed Migraine Centers offers advanced treatments and minimally invasive procedures, including the International Headache Society’s Cephalalgia Award winning Reed Procedure®, to help migraine suffers enjoy a better quality of life. The partner physicians of Reed Migraine Centers continue to engage in pioneering pain management research to find new and more effective ways to control chronic migraine headaches and someday end migraine pain. To learn more about Reed Migraine Center, visit http://www.ReedMigraine.com.

About Neuro Stim Technologies:
Neuro Stim Technologies is a marketing agency specializing in raising the awareness of innovative technologies and advanced procedures that improve the quality of life of those that suffer from chronic pain.

Lauren Smith, Reed Migraine Centers, http://www.reedmigraine.com, 972 707-2820, [email protected]

Modal title

Dr. Reed's Cephalalgia Award winning research article on nerve stimulation migraine treatment.
View PDF
Dr. Reed's Cephalalgia Award winning research article on nerve stimulation migraine treatment.
Dr. Reed's Cephalalgia Award winning research article on nerve stimulation migraine treatment.

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.